Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Humanitarian Device Exemption Treatment Protocol of TheraSphere for Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer

NCT04090645 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT04090645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04090645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Humanitarian Device Exemption Treatment Protocol of TheraSphere for Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer
Lead sponsor
Methodist Health System
Phase
Not applicable
Overall status
Completed
Start date
May 22, 2014
Completion date
April 16, 2021
Enrollment
187 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver, cancer of, non-resectable